These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 15101847)

  • 1. A systematic review of COX-2 inhibitors compared with traditional NSAIDs, or different COX-2 inhibitors for post-operative pain.
    Rømsing J; Møiniche S
    Acta Anaesthesiol Scand; 2004 May; 48(5):525-46. PubMed ID: 15101847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical pharmacology of the selective COX-2 inhibitors].
    Burian M; Geisslinger G
    Orthopade; 2003 Dec; 32(12):1078-87. PubMed ID: 14655004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: a randomized, placebo- and active-comparator-controlled clinical trial.
    Malmstrom K; Daniels S; Kotey P; Seidenberg BC; Desjardins PJ
    Clin Ther; 1999 Oct; 21(10):1653-63. PubMed ID: 10566562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative analgesic effects of celecoxib or rofecoxib after spinal fusion surgery.
    Reuben SS; Connelly NR
    Anesth Analg; 2000 Nov; 91(5):1221-5. PubMed ID: 11049912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review of the analgesic efficacy and tolerability of COX-2 inhibitors in post-operative pain control.
    Chen LC; Elliott RA; Ashcroft DM
    J Clin Pharm Ther; 2004 Jun; 29(3):215-29. PubMed ID: 15153083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of rofecoxib versus celecoxib in treating pain after dental surgery: a single-center, randomized, double-blind, placebo- and active-comparator-controlled, parallel-group, single-dose study using the dental impaction pain model.
    Malmstrom K; Fricke JR; Kotey P; Kress B; Morrison B
    Clin Ther; 2002 Oct; 24(10):1549-60. PubMed ID: 12462285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analgesic efficacy of a single dose of lumiracoxib compared with rofecoxib, celecoxib and placebo in the treatment of post-operative dental pain.
    Kellstein D; Ott D; Jayawardene S; Fricke J
    Int J Clin Pract; 2004 Mar; 58(3):244-50. PubMed ID: 15117090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: a randomized trial.
    Geba GP; Weaver AL; Polis AB; Dixon ME; Schnitzer TJ;
    JAMA; 2002 Jan; 287(1):64-71. PubMed ID: 11754710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cyclooxygenase-2 inhibitors in postoperative pain management].
    Güneş Y; Işik G
    Agri; 2004 Jul; 16(3):7-16. PubMed ID: 15382000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rofecoxib: a review of its use in the management of osteoarthritis, acute pain and rheumatoid arthritis.
    Matheson AJ; Figgitt DP
    Drugs; 2001; 61(6):833-65. PubMed ID: 11398914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs and effectiveness of rofecoxib, celecoxib, and acetaminophen for preventing pain after ambulatory otolaryngologic surgery.
    Watcha MF; Issioui T; Klein KW; White PF
    Anesth Analg; 2003 Apr; 96(4):987-994. PubMed ID: 12651647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are rofecoxib and celecoxib safer NSAIDS?
    Drug Ther Bull; 2000 Nov; 38(11):81-6. PubMed ID: 11138599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COX-2 selective inhibitors in the treatment of arthritis: a rheumatologist perspective.
    Hochberg MC
    Curr Top Med Chem; 2005; 5(5):443-8. PubMed ID: 15974939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celecoxib and rofecoxib. The role of COX-2 inhibitors in dental practice.
    Moore PA; Hersh EV
    J Am Dent Assoc; 2001 Apr; 132(4):451-6. PubMed ID: 11315375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valdecoxib is more efficacious than rofecoxib in relieving pain associated with oral surgery.
    Fricke J; Varkalis J; Zwillich S; Adler R; Forester E; Recker DP; Verburg KM
    Am J Ther; 2002; 9(2):89-97. PubMed ID: 11897923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The burden of acute postoperative pain and the potential role of the COX-2-specific inhibitors.
    Stephens J; Laskin B; Pashos C; Peña B; Wong J
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii40-52. PubMed ID: 14585917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug switching patterns among patients with rheumatoid arthritis and osteoarthritis using COX-2 specific inhibitors and non-specific NSAIDs.
    Zhao SZ; Wentworth C; Burke TA; Makuch RW
    Pharmacoepidemiol Drug Saf; 2004 May; 13(5):277-87. PubMed ID: 15133778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative oral celecoxib versus preoperative oral rofecoxib for pain relief after thyroid surgery.
    Karamanlioğlu B; Arar C; Alagöl A; Colak A; Gemlik I; Süt N
    Eur J Anaesthesiol; 2003 Jun; 20(6):490-5. PubMed ID: 12803270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What have we learned from the large outcomes trials of COX-2 selective inhibitors? The rheumatologist's perspective.
    Hochberg MC
    Clin Exp Rheumatol; 2001; 19(6 Suppl 25):S15-22. PubMed ID: 11695246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cox-2 inhibitors: today and tomorrow.
    McMurray RW; Hardy KJ
    Am J Med Sci; 2002 Apr; 323(4):181-9. PubMed ID: 12003372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.